The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20090525
The Journal of Experimental Medicine, Vol. 206, No. 11, 2469-2481
The Rockefeller University Press, 0022-1007 $30.00
© Jenne et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4005K)
Right arrow PDF+supp data (6731K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Jenne, C. N.
Right arrow Articles by Chun, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenne, C. N.
Right arrow Articles by Chun, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*N-NITROSO-N-ETHYLUREA
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow

Craig N. Jenne1,2, Anselm Enders3, Richard Rivera4, Susan R. Watson1, Alexander J. Bankovich1,2, Joao P. Pereira1,2, Ying Xu1,2, Carla M. Roots3, Joshua N. Beilke1, Arnob Banerjee5, Steven L. Reiner5, Sara A. Miller6, Amy S. Weinmann6, Chris C. Goodnow3, Lewis L. Lanier1, Jason G. Cyster1,2, and Jerold Chun4

1 Department of Microbiology and Immunology and 2 Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143
3 Ramaciotti Immunization Genomics Laboratory, John Curtin School of Medical Research, Australian National University, Canberra ACT 0200, Australia
4 Department of Molecular Biology, Helen L. Dorris Child and Adolescent Neuropsychiatric Disorder Institute, The Scripps Research Institute, La Jolla, CA 92037
5 Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104
6 Department of Immunology, University of Washington, Seattle, WA 98195

CORRESPONDENCE Jason G. Cyster: Jason.Cyster{at}ucsf.edu OR Lewis L. Lanier: lewis.lanier{at}ucsf.edu OR Jerold Chun: jchun{at}scripps.edu

During a screen for ethylnitrosourea-induced mutations in mice affecting blood natural killer (NK) cells, we identified a strain, designated Duane, in which NK cells were reduced in blood and spleen but increased in lymph nodes (LNs) and bone marrow (BM). The accumulation of NK cells in LNs reflected a decreased ability to exit into lymph. This strain carries a point mutation within Tbx21 (T-bet), which generates a defective protein. Duane NK cells have a 30-fold deficiency in sphingosine-1-phosphate receptor 5 (S1P5) transcript levels, and S1P5-deficient mice exhibit an egress defect similar to Duane. Chromatin immunoprecipitation confirms binding of T-bet to the S1pr5 locus. S1P-deficient mice exhibit a more severe NK cell egress block, and the FTY720-sensitive S1P1 also plays a role in NK cell egress from LNs. S1P5 is not inhibited by CD69, a property that may facilitate trafficking of activated NK cells to effector sites. Finally, the accumulation of NK cells within BM of S1P-deficient mice was associated with reduced numbers in BM sinusoids, suggesting a role for S1P in BM egress. In summary, these findings identify S1P5 as a T-bet–induced gene that is required for NK cell egress from LNs and BM.


A. Enders and R. Rivera contributed equally to this paper.

Abbreviations used: ChIP, chromatin immunoprecipitation; ENU, ethylnitrosourea; HA, hemagglutinin; iNKT, invariant NKT; LCMV, lymphocytic choriomeningitis; S1P, sphingosine-1-phosphate; S1P1, S1P receptor 1; SNP, single nucleotide polymorphism.

© 2009 Jenne et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS